ArticleObstetrics and gynecology international2026
Risk Factors for the Prognosis of Endometrioid Endometrial Cancer: A Chinese Cohort Study.
Article in Obstetrics and gynecology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Risk Factors for the Prognosis of Endometrioid Endometrial Cancer: A Chinese Cohort Study.Obstetrics and gynecology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify independent prognostic factors for endometrioid endometrial carcinoma based on a 10-year follow-up Chinese cohort study. Methods: This retrospective study included 142 patients diagnosed with endometrioid endometrial carcinoma from 2009 to 2013. Clinical, pathological, and immunohistochemical data were analyzed. Patients were categorized into three outcome groups: no recurrence, recurrence with ongoing survival, and death group. Kaplan-Meier survival analysis and univariate and multivariate Cox proportional hazards regression analysis were conducted to assess disease-free survival (DFS) and overall survival (OS). Results: Advanced FIGO stage and tumor size ≥ 4 cm were independent predictors of poorer OS. Grade 3 histology also independently correlated with reduced survival. For DFS, tumor size ≥ 3 cm and advanced stage were significant risk factors. Progesterone receptor (PR) positivity and lack of lymphovascular space invasion (LVSI) were significantly associated with better prognosis in univariate analysis but were not retained in multivariate models. Conclusions: Tumor size and FIGO stage are key prognostic factors for recurrence and mortality in endometrioid endometrial carcinoma. Grade 3 histology further worsens the prognosis. Traditional pathological markers continue to be critical for individualized risk assessment and treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.